Skip to main content

Your search for “Cancer” returned 1400 results

Patients with Gastrointestinal Tumors at Higher Risk of Other Cancers

May 1, 2015

…temporal relationship between gastrointestinal stromal tumors (GIST) and other cancers. The results, published by Cancer on April 30, indicate that one in 5.8 patients with GIST will develop additional malignancies before and after their diagnosis.

Researchers Develop New Strategy to Target KRAS Mutant Cancer

September 13, 2017

In a new study, published this month in Cancer Discovery, University of California San Diego School of Medicine researchers report that approximately half of lung and pancreatic cancers that originate with a KRAS mutation become addicted to the gene as they progress.

NIH-Funded Study Shows Increased Prostate Cancer Risk from Vitamin E Supplements

October 11, 2011

…units (I.U.) of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer Prevention (SELECT) Trial. The results of this update will appear October 12, 2011, in the Journal of the American…

MicroRNA Specifically Kills Cancer Cells with Common Mutation

October 2, 2016

…percent of all human cancers have mutations in a gene called KRAS. KRAS-mutant cancers are among the most difficult to treat, with poor survival and resistance to chemotherapy. Researchers at University of California San Diego School of Medicine and Moores Cancer Center used microRNAs to systematically inhibit thousands of other…

Cancer Cells Propagated from Early Prostate Cancer

September 25, 2013

A team of cancer researchers at the University of California, San Diego has identified the existence of precursor cells in early prostate cancers. These cells are resistant to androgen-deprivation therapy, and may drive the subsequent emergence of recurrent or metastatic prostate cancer.

Study Shows Increased Prostate Cancer Risk from Vitamin E Supplements

October 18, 2011

Study Shows Increased Prostate Cancer Risk from Vitamin E Supplements Dr. J. Kellogg Parsons Men who took 400 international units (I.U.) of vitamin E daily had more prostate cancers compared to men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer…

Targeting Newly Discovered Pathway Sensitizes Tumors to Radiation and Chemotherapy

September 3, 2015

In some patients, aggressive cancers can become resistant to chemotherapy and radiation treatments. In a paper published in the journal Nature Communications, University of California, San Diego School of Medicine researchers identified a pathway that causes the resistance and a new therapeutic drug that targets this pathway.

Immunotherapy Research for Head and Neck Cancers Gets Boost from V Foundation Grant

November 27, 2017

A team of University of California San Diego School of Medicine and Moores Cancer Center researchers studying new drugs designed to break resistance to cancer immunotherapy has been awarded a V Foundation for Cancer Research translational grant of $600,000 over three years.

New Screening Tool IDs 95 Percent of Stage 1 Pancreatic Cancer

March 21, 2022

UC San Diego study finds new screening tool flags 95 percent of stage 1 pancreatic cancers.

A New Way to Target Cancers Using ‘Synthetic Lethality’

July 27, 2020

Researchers at Ludwig Institute for Cancer Research and University of California San Diego School of Medicine report that inhibiting a key enzyme caused human cancer cells associated with two major types of breast and ovarian cancer to die and in mouse studies reduced tumor growth.

Category navigation with Social links